Search Criteria: COVID-19 Studies;
C4671026: Study drugs for Children with COVID-19 in Children
Nirmatrelvir and Ritonavir are study drugs for children with COVID-19. These study drugs are only approved by the federal drug administration (FDA) for adults. Research is needed to learn the effectiveness of the study drugs and find the best dose for children with COVID-19. (IRB#: IRB_00155069)
Comparing COVID-19 Boosters for Protection Against the SARS-CoV-2 Virus
This study is to understand better whether and how well COVID-19 booster vaccines protect people from the SARS-CoV-2 virus. The information we gain will help us learn more about how to provide people with better protection against this virus. People in this study will complete online surveys and take at-home COVID-19 tests. Two groups are in the study, and people can choose the group they want to participate. One group does not receive the COVID-19 vaccine, and the other does receive the COVID-19 vaccine. Compensation up to $550 is provided for the completion of study activities. (IRB#: IRB_00172738)
How COVID-19 has Impacted Secondary School Aged Students with Autism
COVID-19 Study
The purpose of this study is to explore the academic, psychological and social experiences of secondary school aged individuals with an autism spectrum disorder during COVID-19. (IRB#: IRB_00135759)
Studying Brain Fog and other Cognitive Dysfunction Symptoms for People with Long COVID
Post-Acute Sequelae of SARS-CoV-2 (PASC) is also known as Long Covid. This study will test three interventions for "brain fog" or cognitive dysfunction that has happened because of infection with COVID. Brain fog may cause confusion, forgetfulness, and lack of focus and mental clarity. The study wants to learn more about interventions to help people with this condition. People in the study will be randomly chosen to receive two treatment interventions delivered online to participants home technology device. People in this study will visit a clinic 3 times to complete surveys, lab tests, and brain function tests. They will also complete brain training sessions at home for 10 weeks and answer follow-up questions about their health and well-being. Participation in this study should last about 6 months. Compensation is provided for participation. (IRB#: IRB_00168634)
Treating healthcare provider burnout using Psilocybin-Assisted Psychotherapy and Mindfulness-Based Stress Reduction
Many healthcare providers on the frontlines of the SARS-CoV-2 pandemic felt burnt out and depressed. We want to see if mindfulness training helps with these feelings. We also want to see if psilocybin-assisted therapy helps with these feelings. The frontline healthcare providers who sign up will get mindfulness training for 8 weeks. Half of the providers will also get psilocybin-assisted therapy. (IRB#: IRB_00152312)
University of Utah Long Covid Registry
COVID-19 Study
Researchers at the University of Utah have established a registry to follow individuals who are experiencing prolonged symptoms after COVID-19 infection. We are interested in following people with "Long Covid" using in depth health surveys and optional blood draws to better understand this condition with the goal of ultimately developing clinical management strategies. (IRB#: IRB_00140978)